About BIOTECON Diagnostics
BIOTECON Diagnostics is a company based in Potsdam (Germany) founded in 1999 was acquired by BioChek in April 2020. BIOTECON Diagnostics operates in a competitive market with competitors including DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
- Headquarter Potsdam, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BIOTECON Diagnostics
Detailed funding history for BIOTECON Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BIOTECON Diagnostics
BIOTECON Diagnostics has secured backing from 1 investor. Prominent investors backing the company include BioChek.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers diagnostic kits and software for poultry and swine health monitoring globally.
|
Locked | Locked | Locked |
Investor details for BIOTECON Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BIOTECON Diagnostics
Investment portfolio details for BIOTECON Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BIOTECON Diagnostics
Detailed financials for BIOTECON Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotecon Diagnostics Comparisons
Peer comparison for BIOTECON Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BIOTECON Diagnostics
BIOTECON Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Molecular assays for disease detection are developed using proprietary technology.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
Detailed competitors of BIOTECON Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotecon Diagnostics
Complete news archive for BIOTECON Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BIOTECON Diagnostics
BIOTECON Diagnostics was founded in 1999.
BIOTECON Diagnostics is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.
Kornelia Berghof Jaeger is the current CEO of BIOTECON Diagnostics.
BIOTECON Diagnostics was founded in 1999 in Potsdam, Germany, within the diagnostics sector. Real-time PCR-based rapid detection technologies, including sample preparation and DNA extraction, are developed, produced, and marketed globally. Operations encompass product development for PCR kits and preparation tools, application development for automation and software, and microbiological services. Product lines such as Foodproof and Microproof are provided, alongside accredited laboratory analyses for standardized and customized microbiological testing.
BIOTECON Diagnostics's top competitors include DermTech, Biocartis and Molbio Diagnostics.
BIOTECON Diagnostics has 1 investor. Key investors include BioChek.